Oncolytics Biotech
ONCY
#10284
Rank
HK$0.41 B
Marketcap
HK$3.20
Share price
-7.21%
Change (1 day)
-61.57%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : HK$0.10 Billion

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are HK$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$66.4 M6.15%
2022-12-31HK$62.56 M4.54%
2021-12-31HK$59.84 M2.61%
2020-12-31HK$58.32 M-50.52%
2019-12-31HK$0.11 B136.48%
2018-12-31HK$49.84 M-18.66%
2017-12-31HK$61.27 M160.9%
2016-12-31HK$23.48 M55.14%
2015-12-31HK$15.13 M-32.87%
2014-12-31HK$22.55 M-48.48%
2013-12-31HK$43.77 M-22.99%
2012-12-31HK$56.83 M14.86%
2011-12-31HK$49.48 M154.17%
2010-12-31HK$19.46 M-37.5%
2009-12-31HK$31.14 M8.09%
2008-12-31HK$28.81 M30.68%
2007-12-31HK$22.05 M19.32%
2006-12-31HK$18.47 M50.71%
2005-12-31HK$12.26 M72.41%
2004-12-31HK$7.11 M15.01%
2003-12-31HK$6.18 M-23.08%
2002-12-31HK$8.04 M-54.78%
2001-12-31HK$17.77 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
HK$845.51 B 778,921.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$512.70 B 472,280.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
HK$1.43 B 1,224.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
HK$0.18 B 72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$251.77 B 231,869.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
HK$0.56 B 423.11%๐Ÿ‡บ๐Ÿ‡ธ USA